Yüklüyor......
Recuperating Biopharmaceutical Aspects of Amphotericin B and Paromomycin Using a Chitosan Functionalized Nanocarrier via Oral Route for Enhanced Anti-leishmanial Activity
The design and development of new pharmaceutical formulations for the existing anti-leishmanial is a new strategic alternate to improve efficacy and safety rather than new drug discovery. Herein hybrid solid lipid nanoparticles (SLN) have been engineered to direct the oral delivery of two anti-leish...
Kaydedildi:
| Yayımlandı: | Front Cell Infect Microbiol |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7593694/ https://ncbi.nlm.nih.gov/pubmed/33178626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcimb.2020.570573 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|